Table 2.
Medical interventions performed in the medical or interventional strategy group
| Variable | Medical strategy (n=38) | Interventional strategy (n=34) |
| Medical treatment | ||
| None | 4 (10.5) | 11 (32.4) |
| Topical alone | 1 (2.6) | 1 (2.9) |
| General alone | 16 (42.1) | 9 (26.5) |
| Both topical and general | 17 (44.7) | 13 (38.2) |
| Topical therapy* | ||
| Endobronchial suctioning | 18 (47.4) | 14 (41.2) |
| Chemical tamponade† | 4 (10.5) | 5 (14.7) |
| Mechanical tamponade‡ | 0 | 0 |
| General measures§ | ||
| Supplemental oxygen | 22 (57.9) | 13 (39.4) |
| Intravenous terlipressin | 5 (13.2) | 6 (18.2) |
| Cough suppression | 0 | 0 |
| Antimicrobial treatment | 15 (39.5) | 14 (42.4) |
Data are n (%).
*Topical measures performed using flexible fibreoptic bronchoscopy.
†Topical tamponade including cold saline solution lavage or epinephrine instillation.
‡Mechanical tamponade including bronchial blockers or Fogarty catheters at the segment or subsegment bronchial levels.
§Data are available for 71 patients (missing for one patient in the interventional strategy).